Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2VQxBD6
via IFTTT